Ameriprise
AHCO icon

Ameriprise’s AdaptHealth AHCO Stock Holding History

Ameriprise’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.5M Buy
2,062,968
+495,422
+32% +$5.53M ﹤0.01% 1481
2026
Q1 		$18.7M Buy
1,567,546
+333,498
+27% +$3.41M ﹤0.01% 1460
2025
Q4 		$12.3M Sell
1,234,048
-32,402
-3% -$309K ﹤0.01% 1758
2025
Q3 		$11.3M Buy
1,266,450
+142,616
+13% +$1.32M ﹤0.01% 1827
2025
Q2 		$10.6M Buy
1,123,834
+509,255
+83% +$4.49M ﹤0.01% 1777
2025
Q1 		$6.66M Sell
614,579
-13,419
-2% -$135K ﹤0.01% 2086
2024
Q4 		$5.98M Buy
627,998
+65,606
+12% +$664K ﹤0.01% 2230
2024
Q3 		$6.32M Buy
562,392
+43,317
+8% +$460K ﹤0.01% 2211
2024
Q2 		$5.19M Sell
519,075
-9,215
-2% -$93.6K ﹤0.01% 2273
2024
Q1 		$6.08M Sell
528,290
-4,360
-0.8% -$37K ﹤0.01% 2212
2023
Q4 		$3.88M Buy
532,650
+25,268
+5% +$199K ﹤0.01% 2531
2023
Q3 		$4.62M Buy
507,382
+84,419
+20% +$1.01M ﹤0.01% 2339
2023
Q2 		$5.15M Sell
422,963
-888,248
-68% -$9.9M ﹤0.01% 2325
2023
Q1 		$16.3M Sell
1,311,211
-83,837
-6% -$1.54M 0.01% 1411
2022
Q4 		$26.8M Sell
1,395,048
-7,878
-0.6% -$167K 0.01% 1045
2022
Q3 		$26.3M Buy
1,402,926
+346,750
+33% +$7.13M 0.01% 1012
2022
Q2 		$19.1M Buy
1,056,176
+857,337
+431% +$13.9M 0.01% 1236
2022
Q1 		$3.19M Buy
198,839
+1,265
+0.6% +$22.7K ﹤0.01% 2706
2021
Q4 		$4.83M Sell
197,574
-2,012
-1% -$47.2K ﹤0.01% 2483
2021
Q3 		$4.65M Buy
199,586
+8,099
+4% +$196K ﹤0.01% 2439
2021
Q2 		$5.25M Sell
191,487
-15,610
-8% -$445K ﹤0.01% 2424
2021
Q1 		$7.61M Buy
207,097
+29,947
+17% +$1.06M ﹤0.01% 2088
2020
Q4 		$6.65M Buy
177,150
+19,962
+13% +$618K ﹤0.01% 2058
2020
Q3 		$3.43M Buy
+157,188
New +$3.3M ﹤0.01% 2341

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise's AHCO Position: Q2 2026 in Review

Ameriprise increased its AdaptHealth (AHCO) stake by 32% in Q2 2026, buying an estimated $5.53M and bringing the position to 2,062,968 shares worth $21.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1481.

Ameriprise first reported a position in AHCO in Q3 2020 and has held it in 24 quarters since. The position peaked at $26.8M in Q4 2022. 238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Ameriprise held 2,062,968 shares of AdaptHealth worth $21.5M as of Q2 2026.
  • Ameriprise bought 495,422 AdaptHealth shares in Q2 2026, an estimated $5.53M.
  • AdaptHealth made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #1481 holding.
  • Ameriprise first reported a position in AdaptHealth in Q3 2020 and has held it in 24 quarters since.
  • Ameriprise's AdaptHealth position peaked at $26.8M in Q4 2022.
  • 238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.